These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 26114963

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).
    Malínková V, Vylíčil J, Kryštof V.
    Expert Opin Ther Pat; 2015; 25(9):953-70. PubMed ID: 26161698
    [Abstract] [Full Text] [Related]

  • 3. Cyclin-dependent kinase inhibitors for the treatment of chronic lymphocytic leukemia.
    Blachly JS, Byrd JC, Grever M.
    Semin Oncol; 2016 Apr; 43(2):265-73. PubMed ID: 27040705
    [Abstract] [Full Text] [Related]

  • 4. Cyclin-Dependent Kinase Inhibitors as Anticancer Therapeutics.
    Law ME, Corsino PE, Narayan S, Law BK.
    Mol Pharmacol; 2015 Nov; 88(5):846-52. PubMed ID: 26018905
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Coming full circle: cyclin-dependent kinases as anti-cancer drug targets.
    Fisher RP.
    Subcell Biochem; 2010 Nov; 50():1-15. PubMed ID: 20012574
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fluorescent biosensors for drug discovery new tools for old targets--screening for inhibitors of cyclin-dependent kinases.
    Prével C, Kurzawa L, Van TN, Morris MC.
    Eur J Med Chem; 2014 Dec 17; 88():74-88. PubMed ID: 25314935
    [Abstract] [Full Text] [Related]

  • 13. Fluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cells.
    Yenugonda VM, Deb TB, Grindrod SC, Dakshanamurthy S, Yang Y, Paige M, Brown ML.
    Bioorg Med Chem; 2011 Apr 15; 19(8):2714-25. PubMed ID: 21440449
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological cyclin dependent kinase inhibitors: Implications for colorectal cancer.
    Balakrishnan A, Vyas A, Deshpande K, Vyas D.
    World J Gastroenterol; 2016 Feb 21; 22(7):2159-64. PubMed ID: 26900281
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Targeting cyclin-dependent kinases in anti-neoplastic therapy.
    Bruyère C, Meijer L.
    Curr Opin Cell Biol; 2013 Dec 21; 25(6):772-9. PubMed ID: 24011867
    [Abstract] [Full Text] [Related]

  • 17. Cyclin-dependent kinases as therapeutic targets in melanoma.
    Miller DM, Flaherty KT.
    Pigment Cell Melanoma Res; 2014 May 21; 27(3):351-65. PubMed ID: 24405945
    [Abstract] [Full Text] [Related]

  • 18. Recent advances on CDK inhibitors: An insight by means of in silico methods.
    Tutone M, Almerico AM.
    Eur J Med Chem; 2017 Dec 15; 142():300-315. PubMed ID: 28802482
    [Abstract] [Full Text] [Related]

  • 19. CDK inhibitors in cancer therapy: what is next?
    Malumbres M, Pevarello P, Barbacid M, Bischoff JR.
    Trends Pharmacol Sci; 2008 Jan 15; 29(1):16-21. PubMed ID: 18054800
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.